Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PARP-1 and its associated nucleases in DNA damage response
Yijie Wang, Weibo Luo, Yingfei Wang
DNA repair (2019) Vol. 81, pp. 102651-102651
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 487
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 403
Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy
Yun Chen, Yuyun Hua, Xinshuai Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 171
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
Jixuan Gao, Hilda A. Pickett
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 515-532
Closed Access | Times Cited: 139
Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases
Ping Huang, Guangwei Chen, Weifeng Jin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7292-7292
Open Access | Times Cited: 87
An insight into the anticancer potentials of lignan arctiin: A comprehensive review of molecular mechanisms
Raihan Chowdhury, Md. Shimul Bhuia, Polrat Wilairatana, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32899-e32899
Open Access | Times Cited: 16
Parps in immune response: Potential targets for cancer immunotherapy
S Wang, Jingling Huang, T. X. Zeng, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116803-116803
Closed Access | Times Cited: 2
Evolution of cellular stress response mechanisms
Dietmar Kültz
Journal of Experimental Zoology Part A Ecological and Integrative Physiology (2020) Vol. 333, Iss. 6, pp. 359-378
Open Access | Times Cited: 102
Nuclear PARPs and genome integrity
Kameron Azarm, Susan Smith
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 285-301
Open Access | Times Cited: 98
Parthanatos and its associated components: Promising therapeutic targets for cancer
Yunxiang Zhou, Lihong Liu, Sifeng Tao, et al.
Pharmacological Research (2020) Vol. 163, pp. 105299-105299
Closed Access | Times Cited: 90
Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer
Michela Chiappa, Federica Guffanti, Francesco Bertoni, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100744-100744
Closed Access | Times Cited: 79
Targeting necroptosis in anticancer therapy: mechanisms and modulators
Ying Wu, Guoqiang Dong, Chunquan Sheng
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 9, pp. 1601-1618
Open Access | Times Cited: 78
Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases
Komal Thapa, Heena Khan, Uma Sharma, et al.
Life Sciences (2020) Vol. 267, pp. 118975-118975
Closed Access | Times Cited: 76
Emerging role of PARP‐1 and PARthanatos in ischemic stroke
Shuiqiao Liu, Weibo Luo, Yingfei Wang
Journal of Neurochemistry (2021) Vol. 160, Iss. 1, pp. 74-87
Open Access | Times Cited: 71
PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
Lotte van Beek, Éilís McClay, Saleha Patel, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5112-5112
Open Access | Times Cited: 68
The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis
Libo Liu, Jiaxiang Li, Yueshuang Ke, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 1
Closed Access | Times Cited: 55
NAD metabolism: Role in senescence regulation and aging
Claudia C.S. Chini, Heidi Soares Cordeiro, Ngan Tran, et al.
Aging Cell (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 36
Omics-based molecular classifications empowering in precision oncology
Zhaokai Zhou, Ting Lin, Shuang Chen, et al.
Cellular Oncology (2024) Vol. 47, Iss. 3, pp. 759-777
Closed Access | Times Cited: 12
Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke
Yang Liu, Lauren Guttman, Valina L. Dawson, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116174-116174
Closed Access | Times Cited: 12
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 12
Targeting DNA Damage Response in Prostate and Breast Cancer
Antje M. Wengner, Arne Scholz, Bernard Haendler
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8273-8273
Open Access | Times Cited: 70
Parthanatos in the pathogenesis of nervous system diseases
Xuanzhong Wang, Pengfei Ge
Neuroscience (2020) Vol. 449, pp. 241-250
Closed Access | Times Cited: 60
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
Desh Deepak Singh, Amna Parveen, Dharmendra Kumar Yadav
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1512-1512
Open Access | Times Cited: 54
Targeting DNA damage response in cardiovascular diseases: from pathophysiology to therapeutic implications
Lin Wu, James R. Sowers, Yingmei Zhang, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 691-709
Closed Access | Times Cited: 34
An auto-photoacoustic melanin-based drug delivery nano-platform for self-monitoring of acute kidney injury therapy via a triple-collaborative strategy
Xuhui Zhao, Jinghua Sun, Jie Dong, et al.
Acta Biomaterialia (2022) Vol. 147, pp. 327-341
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top